Search images on Google      Product Monograph

Active Ingredients:

• octreotide (octreotide acetate), 10 MG/VIAL

DIN: 02503751

Dosage Form(s): POWDER FOR SUSPENSION, SUSTAINED-RELEASE, KIT

Route(s) of Administration: INTRAMUSCULAR

Schedule: Prescription

Company: TEVA CANADA LIMITED  –  official site

ATC:

• H01 - PITUITARY AND HYPOTHALAMIC HORMONES AND ANALOGUES (ATC, WHO, Wiki)
• H01C - HYPOTHALAMIC HORMONES (ATC, WHO)
• H01CB - Antigrowth hormones (ATC, WHO)
• H01CB02 - OCTREOTIDE (WHO)

Reference brand drug: Sandostatin

 

External Links for Octreotide For Injectable Suspension:

Search on Google

• Octreotide For Injectable Suspension side effects
• Octreotide For Injectable Suspension dosage
• octreotide side effects
• octreotide dosage

Teva Canada Limited

Go to Teva website to see drug product details. Sometimes you can find octreotide for injectable suspension photos and/or monograph. If you are a healthcare professional, you may need to enter your license number.